I tend to agree, this sounds suspicious to me - hard to understand why an investor call would be needed to ‘sell’ a good outcome. My guess is that Pharmaxis and BI are interpreting the data differently - i.e. BI are pulling out because they’re not sold on the data, Pharmaxis are trying to keep the dream alive. All speculation of course, but I’m struggling to see how this would be a good outcome from here.
- Forums
- ASX - By Stock
- SNT
- Ann: Investor Conference Call
Ann: Investor Conference Call, page-5
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
|
|||||
Last
4.4¢ |
Change
0.009(25.7%) |
Mkt cap ! $52.53M |
Open | High | Low | Value | Volume |
3.6¢ | 4.4¢ | 3.6¢ | $183.9K | 4.656M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1159 | 4.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.4¢ | 997342 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1159 | 0.041 |
4 | 625000 | 0.040 |
1 | 22550 | 0.039 |
1 | 250000 | 0.038 |
2 | 502702 | 0.037 |
Price($) | Vol. | No. |
---|---|---|
0.044 | 997342 | 3 |
0.045 | 129043 | 2 |
0.046 | 101217 | 2 |
0.048 | 254667 | 1 |
0.049 | 71945 | 5 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |